title: Surrogates, substudies, and real clinical end points in trials of drug-eluting stents.
authors.forename: Dean J
authors.initials: DJ
authors.lastname: Kereiakes
authors.forename: Richard E
authors.initials: RE
authors.lastname: Kuntz
authors.forename: Laura
authors.initials: L
authors.lastname: Mauri
authors.forename: Mitchell W
authors.initials: MW
authors.lastname: Krucoff
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D017327:Clinical Trials, Phase IV as Topic; D003327:Coronary Disease / Q000628:therapy*; D023903:Coronary Restenosis / Q000517:prevention & control*; D006801:Humans; D017239:Paclitaxel / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D015607:Stents
chemical_list: D000970:Antineoplastic Agents; D017239:Paclitaxel